Why do we need quality-assured diagnostic tests for sexually transmitted infections?
about
Advances in plasmonic technologies for point of care applicationsPoint-of-Care Diagnostics for Improving Maternal Health in South Africa.A simple, inexpensive device for nucleic acid amplification without electricity-toward instrument-free molecular diagnostics in low-resource settingsMicro-a-fluidics ELISA for rapid CD4 cell count at the point-of-careEpidemiology of curable sexually transmitted infections among women at increased risk for HIV in northwestern Tanzania: inadequacy of syndromic management.Are Treponema pallidum specific rapid and point-of-care tests for syphilis accurate enough for screening in resource limited settings? Evidence from a meta-analysis.Characterizing the intracellular distribution of metabolites in intact Chlamydia-infected cells by Raman and two-photon microscopy.Poor Performance of the Chlamydia Rapid Test Device for the Detection of Asymptomatic Infections in South African Men: A Pilot StudyFeasibility and Field Performance of a Simultaneous Syphilis and HIV Point-of-Care Test Based Screening Strategy in at Risk Populations in Edmonton, Canada.Diagnostic challenges of sexually transmitted infections in resource-limited settings.Poor Reporting of Outcomes Beyond Accuracy in Point-of-Care Tests for Syphilis: A Call for a FrameworkEvaluation of SD BIOLINE Syphilis 3.0 for Rapid Diagnosis of Syphilis: Report from a Regional Sexually Transmitted Infection Reference Laboratory in North IndiaDesign and Development of a Multiplex Real-Time PCR Assay for Detection of HIV-1 and HCV Using Molecular BeaconsImproving access to new diagnostics through harmonised regulation: priorities for actionSimultaneous triple point-of-care testing for HIV, syphilis and hepatitis B virus to prevent mother-to-child transmission in India.Rapid diagnostic test for antenatal syphilis screening in low-income and middle-income countries: a systematic review and meta-analysis.
P2860
Q27012914-DE52215F-72B9-4B8C-88DC-37D4D5E5A360Q28075858-BCDAEC10-9A01-4F36-89EB-8E2F7DB35EB6Q28478095-DAB1C4E7-6ABB-4DA8-8B72-8050B135195CQ30444143-156715FC-CCDC-4FD1-BC4E-E1F610CDC53CQ33904427-AE793622-4626-4C81-A7FE-10E439AE407AQ34611346-111552F3-BB50-4FA5-AFAF-4EE561337D94Q34642535-41D3E624-64B3-4841-99F9-DF85230CA802Q36861001-816BFF15-F1DD-43F4-AFE7-67C14062B512Q37557359-C5AB1772-3869-4339-A11C-E751C15EE391Q37648697-76CF3CFD-6D5B-4333-8F3D-4DE4E1BE059AQ37700502-7F7832D9-6335-4159-8968-CA88DB4885C4Q38899226-3749307F-EFEE-48A7-ACFF-E49CBCBD4B32Q42272705-FD830FCE-44A1-43AD-BB28-4F22F7F5AE61Q42375494-255D6F50-0D61-4CB3-B9C7-08D57A5B1E1AQ45357266-9AAA3ED6-BFB0-4475-A743-A6A83D25D1CBQ52691695-5A0087CF-A3C2-4717-8426-EF4F909BB6E3
P2860
Why do we need quality-assured diagnostic tests for sexually transmitted infections?
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Why do we need quality-assured diagnostic tests for sexually transmitted infections?
@ast
Why do we need quality-assured diagnostic tests for sexually transmitted infections?
@en
type
label
Why do we need quality-assured diagnostic tests for sexually transmitted infections?
@ast
Why do we need quality-assured diagnostic tests for sexually transmitted infections?
@en
prefLabel
Why do we need quality-assured diagnostic tests for sexually transmitted infections?
@ast
Why do we need quality-assured diagnostic tests for sexually transmitted infections?
@en
P2093
P356
P1476
Why do we need quality-assured diagnostic tests for sexually transmitted infections?
@en
P2093
Alan Herring
Edward W Hook
Rosanna W Peeling
P2888
P304
P356
10.1038/NRMICRO1555
P407
P50
P577
2006-12-01T00:00:00Z